Analyst rates Anthropic, PBC a Buy: enterprise adoption supports compounding; a 50x P/E valuation yields a $140 year-end 2028 ...
Analyst rates Hilton Worldwide a Buy: 6% net room growth leads peers, and 21.5x 2027 EBITDA looks reasonable against 10% ...
Analyst rates Copel a Buy: recurring EBITDA rose 35%, and continued results could return its shares to an 18x average ...
At 10.4x forward EV/E, Ichor Holdings may appear cheap, but low multiples near cycle peaks can mask earnings vulnerability.
Assuming $12.50 as long-run normalized adjusted EPS, to reflect somewhat softer pricing conditions and less favorable ...
Willis Towers Watson ( WTW) is one of the main insurance brokerage and consulting companies, being less exposed to insurance ...
Abrams Capital Management's 13F portfolio fell from $5.48 billion to $4.81 billion, while holdings increased from 10 to 11.
Analyst rates Zurich a Buy as the Beazley deal is expected to deliver $1.8 billion in capital synergies and more than $150 ...
Cousins Properties proved it can create a meaningful revenue recovery trend after the pandemic era's impact on offices.
PDS Biotechnology halted internal PDS0101 development despite 39.3-month median overall survival in phase 2; a strategic ...
Invesco Diversified Dividend Fund underperformed the Russell 1000 Value Index in Q3 2026 due to IT underweighting. Read the ...
Orion S.A. stock has plunged since earnings, hitting an all-time low despite a report that, on its face, seems potentially ...